ARCHIVES

Ending Breast Cancer by 2020? NBCC President Fran Visco Discusses the Goal

This article is from The Cancer Letter archive.

Vol. 39 No. 04 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

Rosenberg Starts New Study With TIL; LAK-IL-2 Costs Clarified

November 28, 1986

Complete List of Recommendations by Centers Committee

October 18, 1996

DCT Board Approves Concepts Of Eight New Biological Response Modifiers Program

July 3, 1981

FDA Selects 23 Survivors To Review Drug Applications.

June 15, 2001

Broder To Leave In March; Sondik To Be Acting Director

January 27, 1995

Letrozole cuts risk of recurrent breast cancer in post-menopausal women.

October 17, 2003